Alpine Associates Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Alpine Associates Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-2,178,157	Closed	-$152M	–	51
2024 Q3	$152M	Buy	2,178,157 +69,286	+3%	+$4.75M	6.95%	2
2024 Q2	$142M	Buy	2,108,871 +294,100	+16%	+$19.8M	6.78%	2
2024 Q1	$125M	Buy	+1,814,771	New	+$122M	4.88%	5

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Alpine Associates Management's AXNX Position: Q4 2024 in Review

Alpine Associates Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 2,178,157 shares — an estimated $152M sold.

Alpine Associates Management first reported a position in AXNX in Q1 2024 and held it in 3 quarters. The position peaked at $152M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Alpine Associates Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Alpine Associates Management sold 2,178,157 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $152M.
Alpine Associates Management first reported a position in Axonics, Inc. Common Stock in Q1 2024 and held it in 3 quarters.
Alpine Associates Management's Axonics, Inc. Common Stock position peaked at $152M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Alpine Associates Management's 13F filing for Q4 2024, filed 7 Feb 2025.